Haplo Peripheral Blood Sct In GVHD Prevention

NCT04473911 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

GVHD
AML
ALL
MDS
MPN
CMML
Hodgkin Lymphoma
Non Hodgkin Lymphoma
Blood Stem Cell Transplant Failure
Graft Vs Host Disease
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Myeloproliferative Disorder
Chronic Myelomonocytic Leukemia
Chemosensitive Hodgkin Lymphoma

Interventions

DRUG: FLUDARABINE
DRUG: CYCLOPHOSPHAMIDE
RADIATION: TBI
DRUG: Melphalan
DRUG: Sirolimus
DRUG: Mycophenolate mofetil
DRUG: RGI-2001
DRUG: CYCLOPHOSPHAMIDE

Sponsor

Zachariah Michael DeFilipp

Collaborators

[object Object]